Health & Medicine

STAT+: Lilly's obesity pill enters the oral GLP-1 game, Novo responds

22 sec read21 views0 listens

Eli Lilly’s weight loss pill, orforglipron, received FDA approval, entering the competitive GLP-1 market. This development signals a significant opportunity for pharmaceutical developers and tech professionals to innovate in AI-driven drug discovery processes. Watch for potential trade tariffs on imported drugs that could impact supply chains and pricing.

Read the full article at STAT News

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

StockWatch: Parabilis Medicines Makes Wall Street History with $770.5M IPO

Parabilis Medicines achieved a record-breaking $770.5 million IPO, the largest ever for a drug developer, with its stock experiencing a significant initial jump. This event is highly relevant for developers and professionals in the biotech and pharma...

Ali Nemati

Biotech & Pharma2 days ago33 sec read

SonoThera Raises $125M to Develop Ultrasound-Mediated Genetic Medicines

SonoThera has secured $125 million in Series B financing to advance its ultrasound-mediated genetic medicine platform toward clinical trials. This development is significant for the biotech sector because the proprietary RIPPLE and PORE technologies ...

Ali Nemati

Biotech & Pharma2 days ago32 sec read

STAT+: Pharmalittle: We're reading about a discontinued cancer drug, a Novo security breach, and more

The nonprofit Blood Cancer United has acquired the remaining supplies and investigational rights for the discontinued drug Luvelta to continue providing it to children with rare blood cancers. This unusual move highlights a critical shift in the phar...

Ali Nemati

Gaming3 days ago32 sec read

Tupac Casting In Stranger Than Heaven Came Directly From Snoop Dogg, RGG Boss Says

RGG Studio has integrated a digital likeness of the late rapper Tupac Shakur into the game Stranger Than Heaven after receiving explicit approval and collaboration from his estate. This development is significant for tech professionals as it demonstr...

Ali Nemati

Biotech & Pharma4 days ago30 sec read

In Silico Devices May Improve Drug Manufacturability

In silico tools, particularly AI-driven predictive models, can significantly improve drug manufacturability by identifying potential issues early in the development process. BigHat Biosciences demonstrates that by augmenting physical experiments with...

Ali Nemati

STAT+: Lilly's obesity pill enters the oral GLP-1 game, Novo responds

Related Articles

StockWatch: Parabilis Medicines Makes Wall Street History with $770.5M IPO

SonoThera Raises $125M to Develop Ultrasound-Mediated Genetic Medicines

STAT+: Pharmalittle: We're reading about a discontinued cancer drug, a Novo security breach, and more

Tupac Casting In Stranger Than Heaven Came Directly From Snoop Dogg, RGG Boss Says

In Silico Devices May Improve Drug Manufacturability